世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 リポソーム製品の世界市場 2022-2026年Global Liposomal Products Market 2022-2026 リポソーム製品の世界市場 2022-2026年 Technavio社はリポソーム製品市場を監視しており、予測期間中に7.81%のCAGRで進行し、2022-2026年に2213.73百万ドルの成長が見込まれています。当レポートでは、リポソー... もっと見る
日本語のページは自動翻訳を利用し作成しています。 
サマリーリポソーム製品の世界市場 2022-2026年Technavio社はリポソーム製品市場を監視しており、予測期間中に7.81%のCAGRで進行し、2022-2026年に2213.73百万ドルの成長が見込まれています。当レポートでは、リポソーム製品市場について、全体的な分析、市場規模と予測、トレンド、成長要因、課題に加えて、約25社のベンダーを対象としたベンダー分析を行っています。 本レポートでは、現在の世界市場のシナリオ、最新のトレンドとドライバー、そして市場全体の環境に関する最新の分析を提供しています。市場を牽引しているのは、真菌性疾患の発生率の上昇と、癌の発生率の増加です。さらに、真菌性疾患の発生率の上昇は、市場の成長を後押しすると予想されます。 リポソーム製品の市場分析には、アプリケーションセグメントと地理的状況が含まれています。 Technavioのリポソーム製品市場は以下のように区分されています。 アプリケーション別 - 癌 - 真菌感染症 - 疼痛管理 - ウィルスワクチン - 光線力学療法 地域別 - 北アメリカ - ヨーロッパ - アジア - ROW 本調査では、今後数年間のリポソーム製品市場の成長を促進する主な理由の一つとして、リポソーム造影剤の採用拡大を挙げています。 Technavio社は、複数の情報源から得られたデータを調査、合成、主要パラメータの分析によってまとめ、市場の詳細なイメージを提示しています。本レポートでは、リポソーム製品市場について以下の領域をカバーしています。 - リポソーム製品の市場サイジング - リポソーム製品市場の予測 - リポソーム製品市場の産業分析 Technavioの堅牢なベンダー分析は、クライアントの市場での地位向上を支援することを目的としています。これに沿って、本レポートでは、リポソーム製品市場の主要ベンダーであるAstellas Pharma Inc.、Bausch Health Companies Inc.、Galen Ltd.、Gilead Sciences Inc.、Johnson and Johnson Inc.、Leadiant Biosciences Inc.、Merrimack Pharmaceuticals Inc.、Pacira BioSciences Inc.、Spectrum Pharmaceuticals Inc.、武田薬品工業株式会社などの詳細な分析を行っています。Ltd.などがあります。また、リポソーム製剤の市場分析レポートには、市場成長に影響を与える今後のトレンドや課題に関する情報も含まれています。これは、企業が戦略を立て、来るべきすべての成長機会を活用するのに役立つものです。 本調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加えて、包括的な市場およびベンダーランドスケープが含まれています。このレポートの詳細については、- https://www.technavio.com/report/liposomal-products-market-industry-analysis をご覧ください。 Technavio社は、複数の情報源から得たデータを調査、合成、要約し、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することで、市場の詳細なイメージを提示しています。また、業界の主要なインフルエンサーを特定することで、様々な市場の側面を提示しています。提示されたデータは包括的で信頼性が高く、一次および二次両方の広範な調査の結果です。Technavio社の市場調査レポートは、正確な市場成長を予測するために、完全な競合状況と、質的および量的調査を用いた詳細なベンダー選択方法と分析を提供しています。 目次• Executive Summaryo Market overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2021 o Market outlook: Forecast for 2021 - 2026 • Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Application o Market segments o Comparison by Application o Cancer - Market size and forecast 2021-2026 o Fungal infections - Market size and forecast 2021-2026 o Pain management - Market size and forecast 2021-2026 o Viral vaccines - Market size and forecast 2021-2026 o Photodynamic therapy - Market size and forecast 2021-2026 o Market opportunity by Application • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2021-2026 o Europe - Market size and forecast 2021-2026 o Asia - Market size and forecast 2021-2026 o ROW - Market size and forecast 2021-2026 o Key leading countries o Market opportunity By Geographical Landscape o Market drivers o Market challenges o Market trends • Vendor Landscape o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Astellas Pharma Inc. o Bausch Health Companies Inc. o Galen Ltd. o Gilead Sciences Inc. o Johnson and Johnson Inc. o Leadiant Biosciences Inc. o Merrimack Pharmaceuticals Inc. o Pacira BioSciences Inc. o Spectrum Pharmaceuticals Inc. o Takeda Pharmaceutical Co. Ltd. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2021 - 2026 ($ million) • 13: Global market: Year-over-year growth 2021 - 2026 (%) • 14: Five forces analysis 2021 & 2026 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2021 • 21: Application - Market share 2021-2026 (%) • 22: Comparison by Application • 23: Cancer - Market size and forecast 2021-2026 ($ million) • 24: Cancer - Year-over-year growth 2021-2026 (%) • 25: Fungal infections - Market size and forecast 2021-2026 ($ million) • 26: Fungal infections - Year-over-year growth 2021-2026 (%) • 27: Pain management - Market size and forecast 2021-2026 ($ million) • 28: Pain management - Year-over-year growth 2021-2026 (%) • 29: Viral vaccines - Market size and forecast 2021-2026 ($ million) • 30: Viral vaccines - Year-over-year growth 2021-2026 (%) • 31: Photodynamic therapy - Market size and forecast 2021-2026 ($ million) • 32: Photodynamic therapy - Year-over-year growth 2021-2026 (%) • 33: Market opportunity by Application • 34: Customer landscape • 35: Market share By Geographical Landscape 2021-2026 (%) • 36: Geographic comparison • 37: North America - Market size and forecast 2021-2026 ($ million) • 38: North America - Year-over-year growth 2021-2026 (%) • 39: Europe - Market size and forecast 2021-2026 ($ million) • 40: Europe - Year-over-year growth 2021-2026 (%) • 41: Asia - Market size and forecast 2021-2026 ($ million) • 42: Asia - Year-over-year growth 2021-2026 (%) • 43: ROW - Market size and forecast 2021-2026 ($ million) • 44: ROW - Year-over-year growth 2021-2026 (%) • 45: Key leading countries • 46: Market opportunity By Geographical Landscape ($ million) • 47: Impact of drivers and challenges • 48: Vendor landscape • 49: Landscape disruption • 50: Industry risks • 51: Vendors covered • 52: Market positioning of vendors • 53: Astellas Pharma Inc. - Overview • 54: Astellas Pharma Inc. - Product and service • 55: Astellas Pharma Inc. - Key offerings • 56: Astellas Pharma Inc. - Key customers • 57: Astellas Pharma Inc. - Segment focus • 58: Bausch Health Companies Inc. - Overview • 59: Bausch Health Companies Inc. - Business segments • 60: Bausch Health Companies Inc. - Key offerings • 61: Bausch Health Companies Inc. - Key customers • 62: Bausch Health Companies Inc. - Segment focus • 63: Galen Ltd. - Overview • 64: Galen Ltd. - Product and service • 65: Galen Ltd. - Key offerings • 66: Galen Ltd. - Key customers • 67: Galen Ltd. - Segment focus • 68: Gilead Sciences Inc. - Overview • 69: Gilead Sciences Inc. - Product and service • 70: Gilead Sciences Inc. - Key offerings • 71: Gilead Sciences Inc. - Key customers • 72: Gilead Sciences Inc. - Segment focus • 73: Johnson and Johnson Inc. - Overview • 74: Johnson and Johnson Inc. - Business segments • 75: Johnson and Johnson Inc. - Key offerings • 76: Johnson and Johnson Inc. - Key customers • 77: Johnson and Johnson Inc. - Segment focus • 78: Leadiant Biosciences Inc. - Overview • 79: Leadiant Biosciences Inc. - Product and service • 80: Leadiant Biosciences Inc. - Key offerings • 81: Leadiant Biosciences Inc. - Key customers • 82: Leadiant Biosciences Inc. - Segment focus • 83: Merrimack Pharmaceuticals Inc. - Overview • 84: Merrimack Pharmaceuticals Inc. - Product and service • 85: Merrimack Pharmaceuticals Inc. - Key offerings • 86: Merrimack Pharmaceuticals Inc. - Key customers • 87: Merrimack Pharmaceuticals Inc. - Segment focus • 88: Pacira BioSciences Inc. - Overview • 89: Pacira BioSciences Inc. - Business segments • 90: Pacira BioSciences Inc. - Key offerings • 91: Pacira BioSciences Inc. - Key customers • 92: Pacira BioSciences Inc. - Segment focus • 93: Spectrum Pharmaceuticals Inc. - Overview • 94: Spectrum Pharmaceuticals Inc. - Product and service • 95: Spectrum Pharmaceuticals Inc. - Key offerings • 96: Spectrum Pharmaceuticals Inc. - Key customers • 97: Spectrum Pharmaceuticals Inc. - Segment focus • 98: Takeda Pharmaceutical Co. Ltd. - Overview • 99: Takeda Pharmaceutical Co. Ltd. - Product and service • 100: Takeda Pharmaceutical Co. Ltd. - Key offerings • 101: Takeda Pharmaceutical Co. Ltd. - Key customers • 102: Takeda Pharmaceutical Co. Ltd. - Segment focus • 103: Currency conversion rates for US$ • 104: Research Methodology • 105: Validation techniques employed for market sizing • 106: Information sources • 107: List of abbreviations
SummaryGlobal Liposomal Products Market 2022-2026 Table of Contents• Executive Summaryo Market overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2021 o Market outlook: Forecast for 2021 - 2026 • Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Application o Market segments o Comparison by Application o Cancer - Market size and forecast 2021-2026 o Fungal infections - Market size and forecast 2021-2026 o Pain management - Market size and forecast 2021-2026 o Viral vaccines - Market size and forecast 2021-2026 o Photodynamic therapy - Market size and forecast 2021-2026 o Market opportunity by Application • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2021-2026 o Europe - Market size and forecast 2021-2026 o Asia - Market size and forecast 2021-2026 o ROW - Market size and forecast 2021-2026 o Key leading countries o Market opportunity By Geographical Landscape o Market drivers o Market challenges o Market trends • Vendor Landscape o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Astellas Pharma Inc. o Bausch Health Companies Inc. o Galen Ltd. o Gilead Sciences Inc. o Johnson and Johnson Inc. o Leadiant Biosciences Inc. o Merrimack Pharmaceuticals Inc. o Pacira BioSciences Inc. o Spectrum Pharmaceuticals Inc. o Takeda Pharmaceutical Co. Ltd. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2021 - 2026 ($ million) • 13: Global market: Year-over-year growth 2021 - 2026 (%) • 14: Five forces analysis 2021 & 2026 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2021 • 21: Application - Market share 2021-2026 (%) • 22: Comparison by Application • 23: Cancer - Market size and forecast 2021-2026 ($ million) • 24: Cancer - Year-over-year growth 2021-2026 (%) • 25: Fungal infections - Market size and forecast 2021-2026 ($ million) • 26: Fungal infections - Year-over-year growth 2021-2026 (%) • 27: Pain management - Market size and forecast 2021-2026 ($ million) • 28: Pain management - Year-over-year growth 2021-2026 (%) • 29: Viral vaccines - Market size and forecast 2021-2026 ($ million) • 30: Viral vaccines - Year-over-year growth 2021-2026 (%) • 31: Photodynamic therapy - Market size and forecast 2021-2026 ($ million) • 32: Photodynamic therapy - Year-over-year growth 2021-2026 (%) • 33: Market opportunity by Application • 34: Customer landscape • 35: Market share By Geographical Landscape 2021-2026 (%) • 36: Geographic comparison • 37: North America - Market size and forecast 2021-2026 ($ million) • 38: North America - Year-over-year growth 2021-2026 (%) • 39: Europe - Market size and forecast 2021-2026 ($ million) • 40: Europe - Year-over-year growth 2021-2026 (%) • 41: Asia - Market size and forecast 2021-2026 ($ million) • 42: Asia - Year-over-year growth 2021-2026 (%) • 43: ROW - Market size and forecast 2021-2026 ($ million) • 44: ROW - Year-over-year growth 2021-2026 (%) • 45: Key leading countries • 46: Market opportunity By Geographical Landscape ($ million) • 47: Impact of drivers and challenges • 48: Vendor landscape • 49: Landscape disruption • 50: Industry risks • 51: Vendors covered • 52: Market positioning of vendors • 53: Astellas Pharma Inc. - Overview • 54: Astellas Pharma Inc. - Product and service • 55: Astellas Pharma Inc. - Key offerings • 56: Astellas Pharma Inc. - Key customers • 57: Astellas Pharma Inc. - Segment focus • 58: Bausch Health Companies Inc. - Overview • 59: Bausch Health Companies Inc. - Business segments • 60: Bausch Health Companies Inc. - Key offerings • 61: Bausch Health Companies Inc. - Key customers • 62: Bausch Health Companies Inc. - Segment focus • 63: Galen Ltd. - Overview • 64: Galen Ltd. - Product and service • 65: Galen Ltd. - Key offerings • 66: Galen Ltd. - Key customers • 67: Galen Ltd. - Segment focus • 68: Gilead Sciences Inc. - Overview • 69: Gilead Sciences Inc. - Product and service • 70: Gilead Sciences Inc. - Key offerings • 71: Gilead Sciences Inc. - Key customers • 72: Gilead Sciences Inc. - Segment focus • 73: Johnson and Johnson Inc. - Overview • 74: Johnson and Johnson Inc. - Business segments • 75: Johnson and Johnson Inc. - Key offerings • 76: Johnson and Johnson Inc. - Key customers • 77: Johnson and Johnson Inc. - Segment focus • 78: Leadiant Biosciences Inc. - Overview • 79: Leadiant Biosciences Inc. - Product and service • 80: Leadiant Biosciences Inc. - Key offerings • 81: Leadiant Biosciences Inc. - Key customers • 82: Leadiant Biosciences Inc. - Segment focus • 83: Merrimack Pharmaceuticals Inc. - Overview • 84: Merrimack Pharmaceuticals Inc. - Product and service • 85: Merrimack Pharmaceuticals Inc. - Key offerings • 86: Merrimack Pharmaceuticals Inc. - Key customers • 87: Merrimack Pharmaceuticals Inc. - Segment focus • 88: Pacira BioSciences Inc. - Overview • 89: Pacira BioSciences Inc. - Business segments • 90: Pacira BioSciences Inc. - Key offerings • 91: Pacira BioSciences Inc. - Key customers • 92: Pacira BioSciences Inc. - Segment focus • 93: Spectrum Pharmaceuticals Inc. - Overview • 94: Spectrum Pharmaceuticals Inc. - Product and service • 95: Spectrum Pharmaceuticals Inc. - Key offerings • 96: Spectrum Pharmaceuticals Inc. - Key customers • 97: Spectrum Pharmaceuticals Inc. - Segment focus • 98: Takeda Pharmaceutical Co. Ltd. - Overview • 99: Takeda Pharmaceutical Co. Ltd. - Product and service • 100: Takeda Pharmaceutical Co. Ltd. - Key offerings • 101: Takeda Pharmaceutical Co. Ltd. - Key customers • 102: Takeda Pharmaceutical Co. Ltd. - Segment focus • 103: Currency conversion rates for US$ • 104: Research Methodology • 105: Validation techniques employed for market sizing • 106: Information sources • 107: List of abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
TechNavio社の分野での最新刊レポート
本レポートと同じKEY WORD（）の最新刊レポート
よくあるご質問TechNavio社はどのような調査会社ですか?テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|